-
1
-
-
33645526144
-
Cancer statistics, 2006
-
Jemal, A., Siegel, R. and Ward, E. (2006) Cancer statistics, 2006. CA Cancer J Clin, 56:2, pp. 106-130.
-
(2006)
CA Cancer J Clin
, vol.56
, Issue.2
, pp. 106-130
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
-
2
-
-
0035211171
-
Carcinoma of the ovary
-
Heintz, A. P., Odicino, F. and Maisonneuve, P. (2001) Carcinoma of the ovary. J Epidemiol Biostat, 6:1, pp. 107-138.
-
(2001)
J Epidemiol Biostat
, vol.6
, Issue.1
, pp. 107-138
-
-
Heintz, A.P.1
Odicino, F.2
Maisonneuve, P.3
-
3
-
-
0028801693
-
Ovarian cancer
-
NIH consensus conference NIH Consensus Development Panel on Ovarian Cancer. JAMA
-
NIH consensus conference (1995) Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA, 273:6, pp. 491-497.
-
(1995)
Screening, Treatment, and Follow-up
, vol.273
, Issue.6
, pp. 491-497
-
-
-
5
-
-
0016586897
-
Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
-
Griffiths, C. T. (1975) Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr, 42, pp. 101-104.
-
(1975)
Natl Cancer Inst Monogr
, vol.42
, pp. 101-104
-
-
Griffiths, C.T.1
-
6
-
-
0346423733
-
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
-
Alberts, D. S., Liu, P. Y. and Hannigan, E. V. (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med, 335:26, pp. 1950-1955.
-
(1996)
N Engl J Med
, vol.335
, Issue.26
, pp. 1950-1955
-
-
Alberts, D.S.1
Liu, P.Y.2
Hannigan, E.V.3
-
7
-
-
0031281766
-
Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?
-
Krepart, G. V. and Lotocki, R. J. (1997) Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?. Gynecol Oncol, 67:2, pp. 208-214.
-
(1997)
Gynecol Oncol
, vol.67
, Issue.2
, pp. 208-214
-
-
Krepart, G.V.1
Lotocki, R.J.2
-
8
-
-
0032077205
-
Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study
-
Eisenkop, S. M., Friedman, R. L. and Wang, H. J. (1998) Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study. Gynecol Oncol, 69:2, pp. 103-108.
-
(1998)
Gynecol Oncol
, vol.69
, Issue.2
, pp. 103-108
-
-
Eisenkop, S.M.1
Friedman, R.L.2
Wang, H.J.3
-
9
-
-
0020460589
-
Clinical cancer research: An embattled species
-
Frei 3rd, E. (1982) Clinical cancer research: An embattled species. Cancer, 50:10, pp. 1979-1992.
-
(1982)
Cancer
, vol.50
, Issue.10
, pp. 1979-1992
-
-
Frei III, E.1
-
10
-
-
0029737381
-
A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
-
Walsh, T. N., Noonan, N. and Hollywood, D. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med, 335:7, pp. 462-467.
-
(1996)
N Engl J Med
, vol.335
, Issue.7
, pp. 462-467
-
-
Walsh, T.N.1
Noonan, N.2
Hollywood, D.3
-
11
-
-
0033776349
-
Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): Improved treatment for gastric adenocarcinoma
-
Weese, J. L., Harbison, S. P. and Stiller, G. D. (2000) Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): Improved treatment for gastric adenocarcinoma. Surgery, 128:4, pp. 564-571.
-
(2000)
Surgery
, vol.128
, Issue.4
, pp. 564-571
-
-
Weese, J.L.1
Harbison, S.P.2
Stiller, G.D.3
-
12
-
-
0028898526
-
Interval debulking of ovarian cancer-an interim measure
-
Berek, J. S. (1995) Interval debulking of ovarian cancer-an interim measure. N Engl J Med, 332:10, pp. 675-677.
-
(1995)
N Engl J Med
, vol.332
, Issue.10
, pp. 675-677
-
-
Berek, J.S.1
-
13
-
-
0020681712
-
Primary cytoreductive surgery for epithelial ovarian cancer
-
Hacker, N. F., Berek, J. S. and Lagasse, L. D. (1983) Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol, 61:4, pp. 413-420.
-
(1983)
Obstet Gynecol
, vol.61
, Issue.4
, pp. 413-420
-
-
Hacker, N.F.1
Berek, J.S.2
Lagasse, L.D.3
-
14
-
-
0026620239
-
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group study
-
Hoskins, W. J., Bundy, B. N. and Thigpen, J. T. (1992) The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group study. Gynecol Oncol, 47:2, pp. 159-166.
-
(1992)
Gynecol Oncol
, vol.47
, Issue.2
, pp. 159-166
-
-
Hoskins, W.J.1
Bundy, B.N.2
Thigpen, J.T.3
-
15
-
-
0033812797
-
A critique of surgical cytoreduction in advanced ovarian cancer
-
Covens, A. L. (2000) A critique of surgical cytoreduction in advanced ovarian cancer. Gynecol Oncol, 78:3, pp. 269-274.
-
(2000)
Gynecol Oncol
, vol.78
, Issue.3
, pp. 269-274
-
-
Covens, A.L.1
-
16
-
-
0026546910
-
Meta-analysis of surgery in advanced ovarian carcinoma: Is maximum cytoreductive surgery an independent determinant of prognosis?
-
Hunter, R. W., Alexander, N. D. and Soutter, W. P. (1992) Meta-analysis of surgery in advanced ovarian carcinoma: Is maximum cytoreductive surgery an independent determinant of prognosis?. Am J Obstet Gynecol, 166:2, pp. 504-511.
-
(1992)
Am J Obstet Gynecol
, vol.166
, Issue.2
, pp. 504-511
-
-
Hunter, R.W.1
Alexander, N.D.2
Soutter, W.P.3
-
17
-
-
2342442115
-
Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays
-
Berchuck, A., Iversen, E. S. and Lancaster, J. M. (2004) Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Am J Obstet Gynecol, 190:4, pp. 910-925.
-
(2004)
Am J Obstet Gynecol
, vol.190
, Issue.4
, pp. 910-925
-
-
Berchuck, A.1
Iversen, E.S.2
Lancaster, J.M.3
-
18
-
-
0033846756
-
Complete cytoreduction: Is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?
-
Naik, R., Nordin, A. and Cross, P. A. (2000) Complete cytoreduction: Is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?. Gynecol Oncol, 78:2, pp. 176-180.
-
(2000)
Gynecol Oncol
, vol.78
, Issue.2
, pp. 176-180
-
-
Naik, R.1
Nordin, A.2
Cross, P.A.3
-
19
-
-
0018569942
-
A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate
-
Goldie, J. H. and Coldman, A. J. (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep, 63:11, pp. 1727-1733.
-
(1979)
Cancer Treat Rep
, vol.63
, Issue.11
, pp. 1727-1733
-
-
Goldie, J.H.1
Coldman, A.J.2
-
20
-
-
0029050211
-
A meta-analysis of residual disease and survival in stage III and IV carcinoma of the ovary
-
Allen, D. G., Heintz, A. P. and Touw, F. W. (1995) A meta-analysis of residual disease and survival in stage III and IV carcinoma of the ovary. Eur J Gynaecol Oncol, 16:5, pp. 349-356.
-
(1995)
Eur J Gynaecol Oncol
, vol.16
, Issue.5
, pp. 349-356
-
-
Allen, D.G.1
Heintz, A.P.2
Touw, F.W.3
-
21
-
-
0036498788
-
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
-
Bristow, R. E., Tomacruz, R. S. and Armstrong, D. K. (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol, 20:5, pp. 1248-1259.
-
(2002)
J Clin Oncol
, vol.20
, Issue.5
, pp. 1248-1259
-
-
Bristow, R.E.1
Tomacruz, R.S.2
Armstrong, D.K.3
-
22
-
-
0024496836
-
Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer
-
Lawton, F. G., Redman, C. W. and Luesley, D. M. (1989) Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer. Obstet Gynecol, 73:1, pp. 61-65.
-
(1989)
Obstet Gynecol
, vol.73
, Issue.1
, pp. 61-65
-
-
Lawton, F.G.1
Redman, C.W.2
Luesley, D.M.3
-
23
-
-
0032926077
-
Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival
-
Schwartz, P. E., Rutherford, T. J. and Chambers, J. T. (1999) Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival. Gynecol Oncol. 72:1, pp. 93-99.
-
(1999)
Gynecol Oncol.
, vol.72
, Issue.1
, pp. 93-99
-
-
Schwartz, P.E.1
Rutherford, T.J.2
Chambers, J.T.3
-
24
-
-
0035876163
-
Neoadjuvant chemotherapy for unresectable ovarian carcinoma: A French multicenter study
-
Ansquer, Y., Leblanc, E. and Clough, K. (2001) Neoadjuvant chemotherapy for unresectable ovarian carcinoma: A French multicenter study. Cancer, 91:12, pp. 2329-2334.
-
(2001)
Cancer
, vol.91
, Issue.12
, pp. 2329-2334
-
-
Ansquer, Y.1
Leblanc, E.2
Clough, K.3
-
25
-
-
27444432441
-
Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma
-
Hegazy, M. A., El-Shafei, M. A. and Setit, A. E. (2005) Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma. World J Surg Oncol, 3:1, p. 57.
-
(2005)
World J Surg Oncol
, vol.3
, Issue.1
, pp. 57
-
-
Hegazy, M.A.1
El-Shafei, M.A.2
Setit, A.E.3
-
26
-
-
0020438372
-
Debulking surgery: Does it increase the quality of survival?
-
Blythe, J. G. and Wahl, T. P. (1982) Debulking surgery: Does it increase the quality of survival?. Gynecol Oncol, 14:3, pp. 396-408.
-
(1982)
Gynecol Oncol
, vol.14
, Issue.3
, pp. 396-408
-
-
Blythe, J.G.1
Wahl, T.P.2
-
27
-
-
0037227417
-
Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: A prospective longitudinal study
-
Chan, Y. M., Ng, T. Y. and Ngan, H. Y. (2003) Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: A prospective longitudinal study. Gynecol Oncol, 88:1, pp. 9-16.
-
(2003)
Gynecol Oncol
, vol.88
, Issue.1
, pp. 9-16
-
-
Chan, Y.M.1
Ng, T.Y.2
Ngan, H.Y.3
-
28
-
-
0028237380
-
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
-
Hoskins, W. J., McGuire, W. P. and Brady, M. F. (1994) The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol, 170:4, pp. 974-979.
-
(1994)
Am J Obstet Gynecol
, vol.170
, Issue.4
, pp. 974-979
-
-
Hoskins, W.J.1
McGuire, W.P.2
Brady, M.F.3
-
29
-
-
0023579941
-
Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma
-
Neijt, J. P., Huinink, W W ten Bokkel and van der Burg, M. E. (1987) Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma. J Clin Oncol, 5:8, pp. 1157-1168.
-
(1987)
J Clin Oncol
, vol.5
, Issue.8
, pp. 1157-1168
-
-
Neijt, J.P.1
Huinink, W.W.2
ten Bokkel van der Burg, M.E.3
-
30
-
-
0028661219
-
Epithelial ovarian carcinoma: Principles of primary surgery
-
Hoskins, W. J. (1994) Epithelial ovarian carcinoma: Principles of primary surgery. Gynecol Oncol, 55:3, pp. S91-S96.
-
(1994)
Gynecol Oncol
, vol.55
, Issue.3
-
-
Hoskins, W.J.1
-
31
-
-
0034823377
-
Identification of prognostic factors in advanced epithelial ovarian carcinoma
-
Chi, D. S., Liao, J. B. and Leon, L. F. (2001) Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol, 82:3, pp. 532-537.
-
(2001)
Gynecol Oncol
, vol.82
, Issue.3
, pp. 532-537
-
-
Chi, D.S.1
Liao, J.B.2
Leon, L.F.3
-
32
-
-
0034111537
-
The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma
-
Chi, D. S., Venkatraman, E. S. and Masson, V. (2000) The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecol Oncol, 77:2, pp. 227-231.
-
(2000)
Gynecol Oncol
, vol.77
, Issue.2
, pp. 227-231
-
-
Chi, D.S.1
Venkatraman, E.S.2
Masson, V.3
-
33
-
-
0035889879
-
Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma
-
Kuhn, W., Rutke, S. and Spathe, K. (2001) Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer, 92:10, pp. 2585-2591.
-
(2001)
Cancer
, vol.92
, Issue.10
, pp. 2585-2591
-
-
Kuhn, W.1
Rutke, S.2
Spathe, K.3
-
34
-
-
0027394686
-
Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma
-
Nelson, B. E., Rosenfield, A. T. and Schwartz, P. E. (1993) Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol, 11:1, pp. 166-172.
-
(1993)
J Clin Oncol
, vol.11
, Issue.1
, pp. 166-172
-
-
Nelson, B.E.1
Rosenfield, A.T.2
Schwartz, P.E.3
-
35
-
-
0029112083
-
Ovarian carcinoma: Value of CT in predicting success of debulking surgery
-
Meyer, J. I., Kennedy, A. W. and Friedman, R. (1995) Ovarian carcinoma: value of CT in predicting success of debulking surgery. AJR Am J Roentgenol, 165:4, pp. 875-878.
-
(1995)
AJR Am J Roentgenol
, vol.165
, Issue.4
, pp. 875-878
-
-
Meyer, J.I.1
Kennedy, A.W.2
Friedman, R.3
-
36
-
-
0034307229
-
A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography
-
Bristow, R. E., Duska, L. R. and Lambrou, N. C. (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer, 89:7, pp. 1532-1540.
-
(2000)
Cancer
, vol.89
, Issue.7
, pp. 1532-1540
-
-
Bristow, R.E.1
Duska, L.R.2
Lambrou, N.C.3
-
37
-
-
12344325535
-
Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer
-
Qayyum, A., Coakley, F. V. and Westphalen, A. C. (2005) Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol, 96:2, pp. 301-306.
-
(2005)
Gynecol Oncol
, vol.96
, Issue.2
, pp. 301-306
-
-
Qayyum, A.1
Coakley, F.V.2
Westphalen, A.C.3
-
38
-
-
0032422162
-
Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients
-
Vergote, I., De Wever, I. and Tjalma, W. (1998) Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients. Gynecol Oncol, 71:3, pp. 431-436.
-
(1998)
Gynecol Oncol
, vol.71
, Issue.3
, pp. 431-436
-
-
Vergote, I.1
De Wever, I.2
Tjalma, W.3
-
39
-
-
0032852036
-
Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: Can the risk be reduced?
-
van Dam, P. A., DeCloedt, J. and Tjalma, W. A. (1999) Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: Can the risk be reduced?. Am J Obstet Gynecol, 181:3, pp. 536-541.
-
(1999)
Am J Obstet Gynecol
, vol.181
, Issue.3
, pp. 536-541
-
-
van Dam, P.A.1
DeCloedt, J.2
Tjalma, W.A.3
-
40
-
-
0038162281
-
Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer
-
Mazzeo, F., Berliere, M. and Kerger, J. (2003) Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer. Gynecol Oncol, 90:1, pp. 163-169.
-
(2003)
Gynecol Oncol
, vol.90
, Issue.1
, pp. 163-169
-
-
Mazzeo, F.1
Berliere, M.2
Kerger, J.3
-
41
-
-
15444369315
-
Neoadjuvant chemotherapy in advanced ovarian cancer: A case-control study
-
Loizzi, V., Cormio, G. and Resta, L. (2005) Neoadjuvant chemotherapy in advanced ovarian cancer: A case-control study. Int J Gynecol Cancer, 15:2, pp. 217-223.
-
(2005)
Int J Gynecol Cancer
, vol.15
, Issue.2
, pp. 217-223
-
-
Loizzi, V.1
Cormio, G.2
Resta, L.3
-
42
-
-
0028952438
-
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer
-
van der Burg, M. E., van Lent, M. and Buyse, M. (1995) The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med, 332:10, pp. 629-634.
-
(1995)
N Engl J Med
, vol.332
, Issue.10
, pp. 629-634
-
-
van der Burg, M.E.1
van Lent, M.2
Buyse, M.3
-
43
-
-
19744365355
-
Secondary surgical cytoreduction for advanced ovarian carcinoma
-
Rose, P. G., Nerenstone, S. and Brady, M. F. (2004) Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med, 351:24, pp. 2489-2497.
-
(2004)
N Engl J Med
, vol.351
, Issue.24
, pp. 2489-2497
-
-
Rose, P.G.1
Nerenstone, S.2
Brady, M.F.3
-
44
-
-
0022722682
-
The potential for optimal (less than or equal to 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: A prospective study
-
Piver, M. S. and Baker, T. (1986) The potential for optimal (less than or equal to 2cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: A prospective study. Gynecol Oncol, 24:1, pp. 1-8.
-
(1986)
Gynecol Oncol
, vol.24
, Issue.1
, pp. 1-8
-
-
Piver, M.S.1
Baker, T.2
-
45
-
-
0034796033
-
Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator
-
Bristow, R. E. and Montz, F. J. (2001) Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator. Gynecol Oncol, 83:1, pp. 39-48.
-
(2001)
Gynecol Oncol
, vol.83
, Issue.1
, pp. 39-48
-
-
Bristow, R.E.1
Montz, F.J.2
-
46
-
-
4444330066
-
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: A change in surgical approach
-
Chi, D. S., Franklin, C. C. and Levine, D. A. (2004) Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: A change in surgical approach. Gynecol Oncol, 94:3, pp. 650-654.
-
(2004)
Gynecol Oncol
, vol.94
, Issue.3
, pp. 650-654
-
-
Chi, D.S.1
Franklin, C.C.2
Levine, D.A.3
-
47
-
-
4444365590
-
Diaphragm resection for ovarian cancer: Technique and short-term complications
-
Cliby, W., Dowdy, S. and Feitoza, S. S. (2004) Diaphragm resection for ovarian cancer: Technique and short-term complications. Gynecol Oncol, 94:3, pp. 655-660.
-
(2004)
Gynecol Oncol
, vol.94
, Issue.3
, pp. 655-660
-
-
Cliby, W.1
Dowdy, S.2
Feitoza, S.S.3
-
48
-
-
34548585925
-
Cytoreductive surgery in advanced ovarian cancer with or without neoadjuvant chemotherapy
-
Abstracts presented for the 30th Annual Meeting of the Society of Gynecologic Oncologists
-
Surwit, E. and Childers, J. (1999) Cytoreductive surgery in advanced ovarian cancer with or without neoadjuvant chemotherapy. Abstracts presented for the 30th Annual Meeting of the Society of Gynecologic Oncologists. Gynecol Oncol, 72, p. 468.
-
(1999)
Gynecol Oncol
, vol.72
, pp. 468
-
-
Surwit, E.1
Childers, J.2
-
49
-
-
0036436430
-
Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: A retrospective case-control study
-
Vrscaj, M. U. and Rakar, S. (2002) Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: A retrospective case-control study. Eur J Gynaecol Oncol, 23:5, pp. 405-410.
-
(2002)
Eur J Gynaecol Oncol
, vol.23
, Issue.5
, pp. 405-410
-
-
Vrscaj, M.U.1
Rakar, S.2
-
50
-
-
0030054309
-
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
-
McGuire, W. P., Hoskins, W. J. and Brady, M. F. (1996) Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med, 334:1, pp. 1-6.
-
(1996)
N Engl J Med
, vol.334
, Issue.1
, pp. 1-6
-
-
McGuire, W.P.1
Hoskins, W.J.2
Brady, M.F.3
-
51
-
-
28944445036
-
Primary chemotherapy and adjuvant tumor debulking in the management of advanced-stage epithelial ovarian cancer
-
Faught, W. and Hopkins, L. (2005) Primary chemotherapy and adjuvant tumor debulking in the management of advanced-stage epithelial ovarian cancer. Int J Gynecol Cancer, 15, pp. 770-775.
-
(2005)
Int J Gynecol Cancer
, vol.15
, pp. 770-775
-
-
Faught, W.1
Hopkins, L.2
-
52
-
-
0041622805
-
Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: A prospective study
-
Eisenkop, S. M., Spirtos, N. M. and Friedman, R. L. (2003) Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: A prospective study. Gynecol Oncol, 90:2, pp. 390-396.
-
(2003)
Gynecol Oncol
, vol.90
, Issue.2
, pp. 390-396
-
-
Eisenkop, S.M.1
Spirtos, N.M.2
Friedman, R.L.3
-
53
-
-
33750145025
-
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
-
Chi, D. S., Eisenhauer, E. L. and Lang, J. (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?. Gynecol Oncol
-
(2006)
Gynecol Oncol
-
-
Chi, D.S.1
Eisenhauer, E.L.2
Lang, J.3
-
54
-
-
0031033211
-
Stage IV ovarian cancer: Impact of surgical debulking
-
Curtin, J. P., Malik, R. and Venkatraman, E. S. (1997) Stage IV ovarian cancer: Impact of surgical debulking. Gynecol Oncol, 64:1, pp. 9-12.
-
(1997)
Gynecol Oncol
, vol.64
, Issue.1
, pp. 9-12
-
-
Curtin, J.P.1
Malik, R.2
Venkatraman, E.S.3
-
55
-
-
0032980903
-
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer
-
Bristow, R. E., Montz, F. J. and Lagasse, L. D. (1999) Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol, 72:3, pp. 278-287.
-
(1999)
Gynecol Oncol
, vol.72
, Issue.3
, pp. 278-287
-
-
Bristow, R.E.1
Montz, F.J.2
Lagasse, L.D.3
|